Insmed Incorporated (INSM)
NASDAQ·Healthcare·Biotechnology
$135.11
-0.64%
Mkt Cap $30.79B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $231.25M | $263.84M | +14.10% | -$1.07 | -$1.54 | -43.93% | — | — |
| Q4 2025 Oct 30, 2025 | $115.45M | $142.34M | +23.30% | -$1.33 | -$1.75 | -31.58% | — | — |
| Q3 2025 Aug 7, 2025 | $104.13M | $107.42M | +3.16% | -$1.30 | -$1.70 | -30.77% | — | — |
| Q2 2025 May 8, 2025 | $91.47M | $92.82M | +1.48% | -$1.34 | -$1.42 | -5.97% | — | — |
| Q1 2025 Feb 20, 2025 | $102.08M | $104.44M | +2.31% | -$1.17 | -$1.32 | -12.82% | — | — |
| Q4 2024 Oct 31, 2024 | $93.36M | $93.42M | +0.07% | -$1.20 | -$1.27 | -5.83% | — | — |
| Q3 2024 Aug 8, 2024 | $87.95M | $90.34M | +2.71% | -$1.24 | -$1.94 | -56.45% | — | — |
| Q2 2024 May 9, 2024 | $77.76M | $75.50M | -2.90% | -$1.24 | -$1.06 | +14.52% | — | — |
| Q1 2024 Feb 22, 2024 | $82.39M | $83.69M | +1.58% | -$1.13 | -$1.28 | -13.27% | — | — |
| Q4 2023 Oct 26, 2023 | $79.13M | $79.07M | -0.07% | -$1.06 | -$1.10 | -3.77% | — | — |
| Q3 2023 Aug 3, 2023 | $70.22M | $77.23M | +9.98% | -$1.10 | -$1.78 | -61.82% | — | — |
| Q2 2023 May 4, 2023 | $64.51M | $65.21M | +1.09% | -$1.08 | -$1.17 | -8.33% | — | — |
| Q1 2023 Feb 23, 2023 | $62.09M | $59.30M | -4.49% | -$1.00 | -$1.20 | -20.00% | — | — |
| Q4 2022 Oct 27, 2022 | $66.85M | $67.73M | +1.31% | -$0.89 | -$1.09 | -22.47% | — | — |
| Q3 2022 Aug 4, 2022 | $58.79M | $65.22M | +10.93% | -$0.89 | -$0.80 | +10.11% | — | — |
| Q2 2022 May 5, 2022 | $53.28M | $53.11M | -0.32% | -$0.91 | -$0.80 | +12.09% | — | — |
| Q1 2022 Feb 17, 2022 | $50.35M | $56.12M | +11.47% | -$0.89 | -$0.95 | -6.74% | — | — |
| Q4 2021 Oct 28, 2021 | $50.21M | $46.76M | -6.88% | -$0.83 | -$0.96 | -15.66% | — | — |
| Q3 2021 Aug 5, 2021 | $43.72M | $45.37M | +3.76% | -$0.85 | -$0.94 | -10.59% | — | — |
| Q2 2021 May 6, 2021 | $41.64M | $40.21M | -3.42% | -$0.91 | -$0.89 | +2.20% | — | — |